Pomerantz Law Firm Announces the Filing of a Class Action Against Qfin Holdings, Inc. and Certain Officers

Qfin faces a securities class action alleging it overstated its resilience to Chinese regulatory headwinds and understated their impact; investors who acquired securities from March 18 through August 25, 2026, may seek lead-plaintiff status by November 27. Q2 2026 revenue fell 31.6% year over year to approximately RMB 3.57 billion, net income dropped 76.8% to RMB 401.4 million, and Q3 non-GAAP net income guidance called for a 67%–73% decline year over year. Qfin ADSs fell $2.18, or 18.91%, to $9.35 on August 26 after the results and outlook were disclosed.

Analysis

The investable issue is not the complaint’s allegation; it is whether QFIN’s earnings base and funding access have structurally reset. The reported collapse in profit combines a one-off tax interpretation change with operating pressure, so extrapolating the full decline would overstate recurring damage. But management’s warning on funding costs and risk controls points to a second-order squeeze: tighter partner-bank appetite can reduce facilitated volume while forcing more conservative borrower selection, weighing both fee revenue and conversion. Regulatory clarification and tax treatment are distinct risks and should not be conflated.

The class action is a weak standalone catalyst: filing and the November 27 lead-plaintiff deadline are procedural, not a finding of liability. Near term, legal headlines may sustain volatility, but the next material repricing catalyst is evidence on quarterly volume, take rates, delinquency/credit performance, funding availability, and whether the tax charge recurs. Over 6–18 months, sustained industry contraction could favor platforms with stronger funding-partner access, while weakening economics for the sector broadly.

Contrarian angle: the post-results selloff may already discount a severe near-term earnings reset; the complaint adds less fundamental information than the operational disclosures. Yet treating the tax charge as the main explanation risks missing a persistent funding and regulation-driven decline. Thesis fails if subsequent results stabilize facilitated volumes and credit metrics, funding costs ease, and guidance stops deteriorating; it strengthens with further cuts or worsening delinquencies.

Key Decisions for Investors

• Do not initiate a short solely on the lawsuit. For a tactical bearish position, wait for a failed rebound toward the post-results breakdown area or a further guidance reduction; size for gap risk and reassess if operating metrics stabilize. No price target is supportable from the supplied data.
• For existing QFIN longs, reduce exposure until filings and the next results separate recurring operating weakness from the one-off tax item. Track facilitated loan volume, partner funding availability/cost, credit performance, and repeat tax charges.
• Treat November 27 as a volatility/watch date, not a merits catalyst. Revisit only if the court docket or company disclosures introduce information beyond the complaint’s allegations.
• Falsification/cover trigger: a clear stabilization in volumes and credit metrics alongside easing funding pressure. Escalation trigger: another guidance cut, deteriorating delinquencies, or evidence that the tax treatment change creates recurring expense.